A Phase I Double-blind, Randomized, Comparator-controlled Study of the Safety and Tolerability of N-acetylcysteine Plus Mesalamine Enema in Subjects With Left-sided Ulcerative Colitis.
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2011
At a glance
- Drugs Mesalazine/acetylcysteine (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Adverse reactions
- 06 Jan 2011 Results reported in an Altheus Therapeutics media release.
- 06 Jan 2011 Status changed from recruiting to completed according to an Altheus Therapeutics media release.
- 19 Dec 2009 New trial record